BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 11497347)

  • 1. Locked nucleic acids: a promising molecular family for gene-function analysis and antisense drug development.
    Orum H; Wengel J
    Curr Opin Mol Ther; 2001 Jun; 3(3):239-43. PubMed ID: 11497347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotide.
    Fluiter K; Frieden M; Vreijling J; Rosenbohm C; De Wissel MB; Christensen SM; Koch T; Ørum H; Baas F
    Chembiochem; 2005 Jun; 6(6):1104-9. PubMed ID: 15861430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LNA-antisense rivals siRNA for gene silencing.
    Jepsen JS; Wengel J
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):188-94. PubMed ID: 15603252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carba-LNA-5MeC/A/G/T modified oligos show nucleobase-specific modulation of 3'-exonuclease activity, thermodynamic stability, RNA selectivity, and RNase H elicitation: synthesis and biochemistry.
    Upadhayaya R; Deshpande SG; Li Q; Kardile RA; Sayyed AY; Kshirsagar EK; Salunke RV; Dixit SS; Zhou C; Földesi A; Chattopadhyaya J
    J Org Chem; 2011 Jun; 76(11):4408-31. PubMed ID: 21500818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.
    Vester B; Wengel J
    Biochemistry; 2004 Oct; 43(42):13233-41. PubMed ID: 15491130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in locked nucleic acid research].
    Li SM; Xu X; Liang HP; Li L
    Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):319-23. PubMed ID: 14992013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclease resistant methylphosphonate-DNA/LNA chimeric oligonucleotides.
    Nagahama K; Veedu RN; Wengel J
    Bioorg Med Chem Lett; 2009 May; 19(10):2707-9. PubMed ID: 19375912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free-radical ring closure to conformationally locked α-L-carba-LNAs and synthesis of their oligos: nuclease stability, target RNA specificity, and elicitation of RNase H.
    Li Q; Yuan F; Zhou C; Plashkevych O; Chattopadhyaya J
    J Org Chem; 2010 Sep; 75(18):6122-40. PubMed ID: 20738147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LNA (locked nucleic acid) and the diastereoisomeric alpha-L-LNA: conformational tuning and high-affinity recognition of DNA/RNA targets.
    Wengel J; Petersen M; Nielsen KE; Jensen GA; Håkansson AE; Kumar R; Sørensen MD; Rajwanshi VK; Bryld T; Jacobsen JP
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):389-96. PubMed ID: 11563053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine tuning of electrostatics around the internucleotidic phosphate through incorporation of modified 2',4'-carbocyclic-LNAs and -ENAs leads to significant modulation of antisense properties.
    Zhou C; Liu Y; Andaloussi M; Badgujar N; Plashkevych O; Chattopadhyaya J
    J Org Chem; 2009 Jan; 74(1):118-34. PubMed ID: 19055352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of sugar-modified oligonucleotides for antisense therapeutics.
    Prakash TP
    Chem Biodivers; 2011 Sep; 8(9):1616-41. PubMed ID: 21922654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising nucleic acid analogs and mimics: characteristic features and applications of PNA, LNA, and morpholino.
    Karkare S; Bhatnagar D
    Appl Microbiol Biotechnol; 2006 Aug; 71(5):575-86. PubMed ID: 16683135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locked nucleic acids: promising nucleic acid analogs for therapeutic applications.
    Veedu RN; Wengel J
    Chem Biodivers; 2010 Mar; 7(3):536-42. PubMed ID: 20232325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energetic aspects of locked nucleic acids quadruplex association and dissociation.
    Petraccone L; Erra E; Randazzo A; Giancola C
    Biopolymers; 2006 Dec; 83(6):584-94. PubMed ID: 16944520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformationally-2',4'-locked Aza-ENA and carbocyclic ribo-thymidine.
    Chattopadhyaya J
    Nucleic Acids Symp Ser (Oxf); 2007; (51):69-70. PubMed ID: 18029590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR studies of fully modified locked nucleic acid (LNA) hybrids: solution structure of an LNA:RNA hybrid and characterization of an LNA:DNA hybrid.
    Nielsen KE; Rasmussen J; Kumar R; Wengel J; Jacobsen JP; Petersen M
    Bioconjug Chem; 2004; 15(3):449-57. PubMed ID: 15149171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent and selective inhibition of gene expression by an antisense heptanucleotide.
    Wagner RW; Matteucci MD; Grant D; Huang T; Froehler BC
    Nat Biotechnol; 1996 Jul; 14(7):840-4. PubMed ID: 9631007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locked nucleic acid: a potent nucleic acid analog in therapeutics and biotechnology.
    Jepsen JS; Sørensen MD; Wengel J
    Oligonucleotides; 2004; 14(2):130-46. PubMed ID: 15294076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformationally controlled high-affinity targeting of RNA or DNA by novel 2'-amino-DNA/LNA mixmers and pyrenyl-functionalized 2'-amino-DNA.
    Kalra N; Babu BR; Parmar VS; Wengel J
    Org Biomol Chem; 2004 Oct; 2(20):2885-7. PubMed ID: 15480448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zorro locked nucleic acid induces sequence-specific gene silencing.
    Ge R; Heinonen JE; Svahn MG; Mohamed AJ; Lundin KE; Smith CI
    FASEB J; 2007 Jun; 21(8):1902-14. PubMed ID: 17314142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.